Hanall Biopharma Co., Ltd. (KRX: 009420)
South Korea flag South Korea · Delayed Price · Currency is KRW
40,900
+400 (0.99%)
Nov 15, 2024, 3:30 PM KST

Hanall Biopharma Market Cap

Hanall Biopharma has a market cap or net worth of 2.07 trillion as of November 18, 2024. Its market cap has increased by 31.13% in one year.

Market Cap
2.07T
Enterprise Value
2.04T
Revenue
130.37B
Ranking
n/a
PE Ratio
n/a
Stock Price
40,900.00

Market Cap Chart

Since August 30, 1995, Hanall Biopharma's market cap has increased from 26.30B to 2.07T, an increase of 7,786.08%. That is a compound annual growth rate of 16.11%.

History

DateMarket Cap% Change
Nov 15, 20242,073.99B-7.65%
Dec 28, 20232,245.71B148.89%
Dec 29, 2022902.29B-16.29%
Dec 30, 20211,077.89B-43.84%
Dec 30, 20201,919.22B3.31%
Dec 30, 20191,857.72B0.28%
Dec 28, 2018 Pro Pro
Dec 28, 2017 Pro Pro
Dec 29, 2016 Pro Pro
Dec 30, 2015 Pro Pro
Dec 30, 2014 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition